semaglutide mechanism difference Spotlight on the of Action of tirzepatide vs semaglutide mechanism of

Within the next five to ten years, the treatment landscape will look dramatically different from today

We are committed to providing our patients with the most advanced options for managing weight, diabetes, and overall metabolic health

Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again

These medications have been studied for over a decade, so we have a robust understanding of their safety and efficacy, she says